SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-054013
Filing Date
2006-03-15
Accepted
2006-03-14 21:55:45
Documents
7
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 713933
2 LIST OF SUBSIDIARIES dex21.htm EX-21 3571
3 CONSENT OF ODENBERG ULLAKKO MURANISHI & CO. LLP dex231.htm EX-23.1 2260
4 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1903
5 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9454
6 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9470
7 SECTION 906 CEO & CFO CERTIFICATION dex32.htm EX-32 4663
  Complete submission text file 0001193125-06-054013.txt   746717
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 06686613
SIC: 2836 Biological Products, (No Diagnostic Substances)